Showing 34,867 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Activism & civil society

Meet Michael Chancley, an Atlanta Resident Now Helming the PrEP Facts Facebook Group

Editor's pick
TheBody
11 October 2020
Quality of life

Is Being Undetectable Enough?

Editor's pick
POZ
11 October 2020
People with limited treatment options

Patients with HIV and four-class drug resistance have high disease burden

Editor's pick
Healio
11 October 2020
Injectable & long-acting HIV treatment

Long-acting injectables work without oral lead-in period

News
11 October 2020
New & experimental HIV treatments

Capsid inhibitor lenacapavir, dosed six-monthly, has high barrier to drug resistance and no cross-resistance to other classes

Editor's pick
i-Base
9 October 2020
Neurological & cognitive problems

ART reduces Alzheimer's prevalence among patients with HIV

Editor's pick
Healio
9 October 2020
PrEP programmes & uptake

UK: Superdrug is now offering PrEP for the first time

Editor's pick
Gay Star News
9 October 2020
Ethnic & cultural minorities

U.S. Immigration and Customs Enforcement Raids Are Stopping Latinx Queer And Trans Men From Getting HIV Care

Editor's pick
Forbes
9 October 2020
Coronavirus

Australia: Resume PrEP, Urge Community Leaders

Editor's pick
Star Observer
9 October 2020
New & experimental HIV treatments

Islatravir plus doravirine remains effective at 96 weeks

News
9 October 2020
Sleep

Promising results for programme to reduce sleep disturbance in people with HIV

News
8 October 2020
Coronavirus

BHIVA ‘2nd COVID peak’ guidance for HIV clinics - plain English version

Editor's pick
BHIVA
8 October 2020
Weight gain & lipodystrophy

Weight gain after switch to an integrase inhibitor does not boost 'bad fat'

News
7 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Sex workers

Lessons from the Ashodaya PrEP project in India

Editor's pick
UNAIDS
7 October 2020
Combatting stigma

Anti-stigma campaign #NormalizingHIVChallenge goes global

Editor's pick
GNP+
7 October 2020
HIV in the arts & media

“Strip AIDS 2020” Delivers Four Comics About HIV Life Today

Editor's pick
POZ
7 October 2020
Injectable & long-acting HIV treatment

Injectable HIV therapy should save money if adherence is better than to oral therapies

News
7 October 2020
Weight gain & lipodystrophy

Weight gain on HIV treatment: what is normal, and what is harmful?

News
7 October 2020

Dementia in men – HIV update, 7 October 2020

October 2020
Hepatitis & HIV

Virologists who discovered hepatitis C win medicine Nobel

Editor's pick
Nature
5 October 2020
Injectable & long-acting HIV treatment

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey

News
5 October 2020
HIV in the arts & media

Russell T Davies shares first-look teaser and title change for new drama Boys, now It’s A Sin

Editor's pick
Radio Times
4 October 2020
Pharmaceutical industry

US: Gilead's Truvada faces Teva generics assault amid Descovy switching campaign

Editor's pick
FiercePharma
4 October 2020